chr4-78058023-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025074.7(FRAS1):c.14A>T(p.Lys5Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025074.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRAS1 | NM_025074.7 | c.14A>T | p.Lys5Ile | missense_variant | 1/74 | ENST00000512123.4 | |
FRAS1 | NM_001166133.2 | c.14A>T | p.Lys5Ile | missense_variant | 1/42 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRAS1 | ENST00000512123.4 | c.14A>T | p.Lys5Ile | missense_variant | 1/74 | 5 | NM_025074.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152036Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248536Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134848
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461644Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727108
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74270
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 28, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with FRAS1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.005%). This sequence change replaces lysine, which is basic and polar, with isoleucine, which is neutral and non-polar, at codon 5 of the FRAS1 protein (p.Lys5Ile). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at